Comparison of multi-omics results between patients with acute myeloid leukemia with long-term survival and healthy controls

BACKGROUND: Acute myeloid leukemia (AML) is a group of highly heterogeneous diseases, for which approximately 35–40% of patients younger than 60 years old can be cured. However, the multi-omics characteristics and immune cell infiltration (ICI) status of adult long-term survival patients with AML pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yang, Hao, Qishan, Zhang, Guangji, Fang, Qiuyun, Wang, Zhe, Li, Yan, Wei, Hui, Wang, Ying, Jiang, Erlie, Tian, Zheng, Jia, Yannan, Wang, Min, Wang, Jianxiang, Mi, Yingchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848452/
https://www.ncbi.nlm.nih.gov/pubmed/35282130
http://dx.doi.org/10.21037/atm-21-6681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848452/
https://www.ncbi.nlm.nih.gov/pubmed/35282130
http://dx.doi.org/10.21037/atm-21-6681

Ejemplares similares